Ontology of Drug Adverse Events

Last uploaded: January 12, 2019
Jump to:
Preferred Name

Cytarabine [Chemical/Ingredient]
Synonyms
ID

http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000006080
code

C22504
Display_Name

Cytarabine
imported from

http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl
label

Cytarabine [Chemical/Ingredient]
MeSH_CUI

M0005564
MeSH_Definition

A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
MeSH_DUI

D003561
MeSH_Name

Cytarabine
NUI

N0000006080
prefixIRI

NDF-RT:N0000006080
prefLabel

Cytarabine [Chemical/Ingredient]
RxNorm_CUI

3041
RxNorm_Name

Cytarabine
Synonym

Aracytidine

2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-

Cytosine Arabinoside

Arabinofuranosylcytosine

Arabinosylcytosine
UMLS_CUI

C0010711
subClassOf

http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007990

http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007916
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display